Atb Cap Markets Predicts Jushi’s Q1 Earnings (OTCMKTS:JUSHF)

Jushi Holdings Inc. (OTCMKTS:JUSHF) – Stock analysts at Atb Cap Markets issued their Q1 2025 earnings per share estimates for Jushi in a research note issued on Sunday, March 9th. Atb Cap Markets analyst F. Gomes anticipates that the company will post earnings per share of ($0.07) for the quarter. Atb Cap Markets currently has a “Strong Sell” rating on the stock. The consensus estimate for Jushi’s current full-year earnings is ($0.23) per share. Atb Cap Markets also issued estimates for Jushi’s Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.06) EPS, FY2025 earnings at ($0.25) EPS, FY2026 earnings at ($0.20) EPS, FY2027 earnings at ($0.16) EPS and FY2028 earnings at ($0.12) EPS.

Jushi Stock Performance

Shares of JUSHF opened at $0.28 on Wednesday. Jushi has a 52 week low of $0.22 and a 52 week high of $0.92. The firm has a market capitalization of $55.80 million, a P/E ratio of -1.05 and a beta of -0.83. The company has a 50-day simple moving average of $0.33 and a 200-day simple moving average of $0.39.

Jushi (OTCMKTS:JUSHF) last issued its quarterly earnings results on Wednesday, March 12th. The company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.02). The business had revenue of $65.86 million for the quarter, compared to analysts’ expectations of $64.03 million.

About Jushi

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.